Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomasz Skorski

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Leukemia & Lymphoma|April 10, 2008
BCR/ABL, DNA damage and DNA repair: implications for new treatment conceptsTomasz Skorski
Nature Reviews. Cancer|June 5, 2002
Oncogenic tyrosine kinases and the DNA-damage responseTomasz Skorski
Oncogene|December 12, 2002
BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instabilityTomasz Skorski
Current Hematologic Malignancy Reports|April 29, 2010
Genomic instability: The cause and effect of BCR/ABL tyrosine kinaseTomasz Skorski
Chemistry & Biology|November 29, 2011
BCR-ABL1 kinase: hunting an elusive target with new weaponsTomasz Skorski
Current Hematologic Malignancy Reports|February 14, 2012
Genetic mechanisms of chronic myeloid leukemia blastic transformationTomasz Skorski
Leukemia & Lymphoma|February 9, 2011
Chronic myeloid leukemia cells refractory/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease stateTomasz Skorski
Experimental Hematology|December 14, 2004
NPM/ALK downregulates p27Kip1 in a PI-3K-dependent mannerArtur Slupianek, Tomasz Skorski
Leukemia|September 2, 2024
Star wars against leukemia: attacking the clonesMonika M Toma, Tomasz Skorski
Postepy Higieny I Medycyny Doswiadczalnej (Online)|September 18, 2014
[Synthetic lethality as a functional tool in basic research and in anticancer therapy]Monika Toma, Tomasz Skorski, Tomasz Sliwiński
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Leukemia & Lymphoma|April 10, 2008
BCR/ABL, DNA damage and DNA repair: implications for new treatment conceptsTomasz Skorski
Nature Reviews. Cancer|June 5, 2002
Oncogenic tyrosine kinases and the DNA-damage responseTomasz Skorski
Oncogene|December 12, 2002
BCR/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instabilityTomasz Skorski
Current Hematologic Malignancy Reports|April 29, 2010
Genomic instability: The cause and effect of BCR/ABL tyrosine kinaseTomasz Skorski
Chemistry & Biology|November 29, 2011
BCR-ABL1 kinase: hunting an elusive target with new weaponsTomasz Skorski
Current Hematologic Malignancy Reports|February 14, 2012
Genetic mechanisms of chronic myeloid leukemia blastic transformationTomasz Skorski
Leukemia & Lymphoma|February 9, 2011
Chronic myeloid leukemia cells refractory/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease stateTomasz Skorski
Experimental Hematology|December 14, 2004
NPM/ALK downregulates p27Kip1 in a PI-3K-dependent mannerArtur Slupianek, Tomasz Skorski
Leukemia|September 2, 2024
Star wars against leukemia: attacking the clonesMonika M Toma, Tomasz Skorski
Postepy Higieny I Medycyny Doswiadczalnej (Online)|September 18, 2014
[Synthetic lethality as a functional tool in basic research and in anticancer therapy]Monika Toma, Tomasz Skorski, Tomasz Sliwiński
Pageof 12